CDH1 and cancer: For these reasons, methylation of this gene has been investigated as a biomarker of the prediction of cancer development in 207 non-neoplastic patients and, together with CDH1, was found to be a promising liquid biopsy biomarker for early cancer diagnosis and prognosis prediction [70,71,72,73].